Transdifferentiation of bone marrow-derived endothelial progenitor cells into the smooth muscle cell lineage mediated by tansforming growth factor-β1

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 114-121

  Imamura, Hirotoshi ^a   Ohta, Tsuyoshi ^b   Tsunetoshi, Kenzo ^c   Doi, Kent ^a   Nozaki, Kazuhiko ^d   Takagi, Yasushi ^a   Kikuta, Ken ichiro ^c  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kitano Hospital   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Differentiation; Endothelial progenitor cell; Intimal hyperplasia; Smooth muscle cell; Transforming growth factor beta 1

Indexed keywords

FIBRONECTIN; NEUTRALIZING ANTIBODY; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BONE MARROW CELL; CAROTID ARTERY INJURY; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; ENDOTHELIUM CELL; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; WESTERN BLOTTING; ANIMAL; CYTOLOGY; INTIMA; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STEM CELL;

ANIMALS; BONE MARROW CELLS; CELL LINEAGE; CELL TRANSDIFFERENTIATION; ENDOTHELIAL CELLS; MALE; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; TUNICA INTIMA;

EID: 77954253573     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.040     Document Type: Article

References (30)

1. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Werner N., Junk S., Laufs U., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003, 93:e17-e24.
3. Boyer M., Townsend L.E., Vogel L.M., et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J Vasc Surg 2000, 31:181-189.
4. Shintani S., Murohara T., Ikeda H., et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001, 103:897-903.
5. Kawamoto A., Tkebuchava T., Yamaguchi J., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003, 107:461-468.
6. Ohta T., Kikuta K., Imamura H., et al. Administration of ex vivo-expanded bone marrow-derived endothelial progenitor cells attenuates focal cerebral ischemia-reperfusion injury in rats. Neurosurgery 2006, 59:679-686.
7. Takamiya M., Okigaki M., Jin D., et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2006, 26:751-757.
8. Strehlow K., Werner N., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003, 107:3059-3065.
9. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024.
10. Kong D., Melo L.G., Mangi A.A., et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004, 109:1769-1775.
11. Griese D.P., Achatz S., Batzlsperger C.A., et al. Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells. Cardiovasc Res 2003, 58:469-477.
12. Aoki J., Serruys P.W., van Beusekom H., et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 2005, 45:1574-1579.
13. Lindner V.L., Reidy M.A. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study. Circ Res 1993, 73:589-595.
14. Uchida K., Sasahara M., Morigami N., et al. Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis 1996, 124:9-23.
15. Majesky M.W., Lindner V., Twardzik D.R., et al. Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest 1991, 88:904-910.
16. Wolf Y.G., Rasmussen L.M., Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest 1994, 93:1172-1178.
17. Miyata T., Iizasa H., Sai Y., et al. Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J Cell Physiol 2005, 204:948-955.
18. Oda M., Arakawa Y., Kano H., et al. Quantitative analysis of topoisomerase IIalpha to rapidly evaluate cell proliferation in brain tumors. Biochem Biophys Res Commun 2005, 331:971-976.
19. Howson K.M., Aplin A.C., Gelati M., et al. The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture. Am J Physiol Cell Physiol 2005, 289:1396-1407.
20. Oliver J.A., Barasch J., Yang J., et al. Metanephric mesenchyme contains embryonic renal stem cells. Am J Physiol Renal Physiol 2002, 283:F799-809.
21. Wen C.Y., Ito M., Wang H., et al. IL-11 up-regulates Tie-2 expression during the healing of gastric ulcers in rats. World J Gastroenterol 2003, 9:788-790.
22. Tsang M.L., Zhou L., Zheng B.L., et al. Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII). Cytokine 1995, 7:389-397.
23. Johannes W., Kerstin D., Torsten B., et al. Cyclosporine A up-regulates the expression of TGF-β1 and its receptors type I and type II in rat mesangial cells. Nephrol Dial Transplant 2002, 17:1568-1577.
24. Frid M.G., Kale V.A., Stenmark K.R., et al. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002, 90:1189-1196.
25. Arciniegas E., Sutton A.B., Allen T.D., et al. Transforming growth factor β1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 1992, 103:521-529.
26. Fadini G.P., Baesso I., Albiero M., Sartore S., Agostini C., Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008, 197:496-503.
27. Sinha S., Hoofnagle M.H., Kingston P.A., et al. Transforming growth factor-β1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 2004, 287:C1560-C1568.
28. Ninomiya K., Takahashi A., Fujioka Y., et al. Transforming growth factor-β signaling enhances transdifferentiation of macrophages into smooth muscle-like cells. Hypertens Res 2006, 29:269-276.
29. Sata M., Saiura M.A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409.
30. Wrana J.L., Attisano L., Carcamo J., et al. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 1992, 71:1003-1014.